Langerhans cells serve as immunoregulatory cells by activating NKT cells

Journal of Immunology

Volumn 185, Issue 8, 2010, Pages 4633-4640

  Fukunaga, Atsushi ^a,b   Khaskhely, Noor M ^a   Ma, Ying ^a   Sreevidya, Coimbatore S ^a   Taguchi, Kumiko ^b   Nishigori, Chikako ^b   Ullrich, Stephen E ^a,c  

^a UNIVERSITY OF TEXAS   (United States)

^b KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 4;

ANIMAL CELL; ARTICLE; CELL ACTIVATION; CELL ISOLATION; CELL SURVIVAL; FEMALE; IMMUNOREGULATION; IMMUNOSUPPRESSIVE TREATMENT; LANGERHANS CELL; LYMPH NODE; MOUSE; NATURAL KILLER T CELL; NONHUMAN; PRIORITY JOURNAL; ULTRAVIOLET RADIATION; WILD TYPE; ANIMAL; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; NEUTROPHIL CHEMOTAXIS; RADIATION EXPOSURE;

ANIMALS; CHEMOTAXIS, LEUKOCYTE; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNE TOLERANCE; LANGERHANS CELLS; LYMPHOCYTE ACTIVATION; MICE; NATURAL KILLER T-CELLS; ULTRAVIOLET RAYS;

EID: 78049495085     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1000246     Document Type: Article

References (50)

1. Wolff, K. 1967. The fine structure of the Langerhans cell granule. J. Cell Biol. 35:468-473.
2. Valladeau, J., O. Ravel, C. Dezutter-Dambuyant, K. Moore, M. Kleijmeer, Y. Liu, V. Duvert-Frances, C. Vincent, D. Schmitt, J. Davoust, et al. 2000. Langerin, a novel C-type lectin specific to Langerhans cells, is an endocytic receptor that induces the formation of Birbeck granules. Immunity 12:71-81.
3. Kripke, M. L., C. G. Munn, A. Jeevan, J. M. Tang, and C. Bucana. 1990. Evidence that cutaneous antigen-presenting cells migrate to regional lymph nodes during contact sensitization. J. Immunol. 145:2833-2838.
4. Bennett, C. L., E. van Rijn, S. Jung, K. Inaba, R. M. Steinman, M. L. Kapsenberg, and B. E. Clausen. 2005. Inducible ablation of mouse Langerhans cells diminishes but fails to abrogate contact hypersensitivity. J. Cell Biol. 169:569-576.
5. Kaplan, D. H., M. C. Jenison, S. Saeland, W. D. Shlomchik, and M. J. Shlomchik. 2005. Epidermal langerhans cell-deficient mice develop enhanced contact hypersensitivity. Immunity 23:611-620.
6. Kissenpfennig, A., S. Henri, B. Dubois, C. Laplace-Builhé, P. Perrin, N. Romani, C. H. Tripp, P. Douillard, L. Leserman, D. Kaiserlian, et al. 2005. Dynamics and function of Langerhans cells in vivo: dermal dendritic cells colonize lymph node areas distinct from slower migrating Langerhans cells. Immunity 22:643-654.
7. Ritter, U., A. Meissner, C. Scheidig, and H. Körner. 2004. CD8 alpha-and Langerin-negative dendritic cells, but not Langerhans cells, act as principal antigen-presenting cells in leishmaniasis. Eur. J. Immunol. 34:1542-1550.
8. Fukunaga, A., N. M. Khaskhely, C. S. Sreevidya, S. N. Byrne, and S. E. Ullrich. 2008. Dermal dendritic cells, and not Langerhans cells, play an essential role in inducing an immune response. J. Immunol. 180:3057-3064.
9. Obhrai, J. S., M. Oberbarnscheidt, N. Zhang, D. L. Mueller, W. D. Shlomchik, F. G. Lakkis, M. J. Shlomchik, and D. H. Kaplan. 2008. Langerhans cells are not required for efficient skin graft rejection. J. Invest. Dermatol. 128:1950-1955.
10. Merad, M., P. Hoffmann, E. Ranheim, S. Slaymaker, M. G. Manz, S. A. Lira, I. Charo, D. N. Cook, I. L. Weissman, S. Strober, and E. G. Engleman. 2004. Depletion of host Langerhans cells before transplantation of donor alloreactive T cells prevents skin graft-versus-host disease. Nat. Med. 10:510-517.
11. Waithman, J., R. S. Allan, H. Kosaka, H. Azukizawa, K. Shortman, M. B. Lutz, W. R. Heath, F. R. Carbone, and G. T. Belz. 2007. Skin-derived dendritic cells can mediate deletional tolerance of class I-restricted self-reactive T cells. J. Immunol. 179:4535-4541.
12. Cooper, K. D., L. Oberhelman, T. A. Hamilton, O. Baadsgaard, M. Terhune, G. LeVee, T. Anderson, and H. Koren. 1992. UVexposure reduces immunization rates and promotes tolerance to epicutaneous antigens in humans: relationship to dose, CD1a-DR+ epidermal macrophage induction, and Langerhans cell depletion. Proc. Natl. Acad. Sci. USA 89:8497-8501.
13. Elmets, C. A., P. R. Bergstresser, R. E. Tigelaar, P. J. Wood, and J. W. Streilein. 1983. Analysis of the mechanism of unresponsiveness produced by haptens painted on skin to low dose ultraviolet radiation. J. Exp. Med. 158:781-794.
14. Toews, G. B., P. R. Bergstresser, and J. W. Streilein. 1980. Epidermal Langerhans cell density determines whether contact hypersensitivity or unresponsiveness follows skin painting with DNFB. J. Immunol. 124:445-453.
15. Stingl, G. L., L. A. Gazze-Stingl, W. Aberer, and K. Wolff. 1981. Antigen presentation by murine epidermal langerhans cells and its alteration by ultraviolet B light. J. Immunol. 127:1707-1713.
16. Okamoto, H., and M. L. Kripke. 1987. Effector and suppressor circuits of the immune response are activated in vivo by different mechanisms. Proc. Natl. Acad. Sci. USA 84:3841-3845.
17. Simon, J. C., R. E. Tigelaar, P. R. Bergstresser, D. Edelbaum, and P. D. Cruz, Jr. 1991. Ultraviolet B radiation converts Langerhans cells from immunogenic to tolerogenic antigen-presenting cells. Induction of specific clonal anergy in CD4+ T helper 1 cells. J. Immunol. 146:485-491.
18. Weiss, J. M., A. C. Renkl, R. W. Denfeld, R. de Roche, M. Spitzlei, E. Schöpf, and J. C. Simon. 1995. Low-dose UVB radiation perturbs the functional expression of B7.1 and B7.2 co-stimulatory molecules on human Langerhans cells. Eur. J. Immunol. 25:2858-2862.
19. Vink, A. A., A. M. Moodycliffe, V. Shreedhar, S. E. Ullrich, L. Roza, D. B. Yarosh, and M. L. Kripke. 1997. The inhibition of antigen-presenting activity of dendritic cells resulting from UV irradiation of murine skin is restored by in vitro photorepair of cyclobutane pyrimidine dimers. Proc. Natl. Acad. Sci. USA 94:5255-5260.
20. Vink, A. A., F. M. Strickland, C. Bucana, P. A. Cox, L. Roza, D. B. Yarosh, and M. L. Kripke. 1996. Localization of DNA damage and its role in altered antigenpresenting cell function in ultraviolet-irradiated mice. J. Exp. Med. 183:1491-1500.
21. Urbach, F. 1997. Ultraviolet radiation and skin cancer of humans. J. Photochem. Photobiol. B 40:3-7.
22. Yoshikawa, T., V. Rae, W. Bruins-Slot, J. W. Van den Berg, J. R. Taylor, and J. W. Streilein. 1990. Susceptibility to effects of UVB radiation on induction of contact hypersensitivity as a risk factor for skin cancer in humans. J. Invest. Dermatol. 95:530-536.
23. Douillard, P., P. Stoitzner, C. H. Tripp, V. Clair-Moninot, S. Aït-Yahia, A. D. McLellan, A. Eggert, N. Romani, and S. Saeland. 2005. Mouse lymphoid tissue contains distinct subsets of langerin/CD207 dendritic cells, only one of which represents epidermal-derived Langerhans cells. J. Invest. Dermatol. 125:983-994.
24. Fukunaga, A., H. Nagai, X. Yu, S. Oniki, H. Okazawa, S. Motegi, R. Suzuki, N. Honma, T. Matozaki, C. Nishigori, and T. Horikawa. 2006. Src homology 2 domain-containing protein tyrosine phosphatase substrate 1 regulates the induction of Langerhans cell maturation. Eur. J. Immunol. 36:3216-3226.
25. Ginhoux, F., M. P. Collin, M. Bogunovic, M. Abel, M. Leboeuf, J. Helft, J. Ochando, A. Kissenpfennig, B. Malissen, M. Grisotto, et al. 2007. Bloodderived dermal langerin+ dendritic cells survey the skin in the steady state. J. Exp. Med. 204:3133-3146.
26. Miyauchi, H., and T. Horio. 1995. Ultraviolet B-induced local immunosuppression of contact hypersensitivity is modulated by ultraviolet irradiation and hapten application. J. Invest. Dermatol. 104:364-369.
27. Matsumura, Y., S. N. Byrne, D. X. Nghiem, Y. Miyahara, and S. E. Ullrich. 2006. A role for inflammatory mediators in the induction of immunoregulatory B cells. J. Immunol. 177:4810-4817.
28. Bursch, L. S., L. Wang, B. Igyarto, A. Kissenpfennig, B. Malissen, D. H. Kaplan, and K. A. Hogquist. 2007. Identification of a novel population of Langerin+ dendritic cells. J. Exp. Med. 204:3147-3156.
29. Henri, S., L. F. Poulin, S. Tamoutounour, L. Ardouin, M. Guilliams, B. de Bovis, E. Devilard, C. Viret, H. Azukizawa, A. Kissenpfennig, and B. Malissen. 2010. CD207+ CD103+ dermal dendritic cells cross-present keratinocyte-derived antigens irrespective of the presence of Langerhans cells. J. Exp. Med. 207:189-206.
30. Stutte, S., B. Jux, C. Esser, and I. Förster. 2008. CD24a expression levels discriminate Langerhans cells from dermal dendritic cells in murine skin and lymph nodes. J. Invest. Dermatol. 128:1470-1475.
31. Yoshiki, R., K. Kabashima, J. I. Sakabe, K. Sugita, T. Bito, M. Nakamura, B. Malissen, and Y. Tokura. 2010. The mandatory role of IL-10-producing and OX40 ligand-expressing mature Langerhans cells in local UVB-induced immunosuppression. J. Immunol. 184:5670-5677.
32. Byrne, S. N., A. Y. Limón-Flores, and S. E. Ullrich. 2008. Mast cell migration from the skin to the draining lymph nodes upon ultraviolet irradiation represents a key step in the induction of immune suppression. J. Immunol. 180:4648-4655.
33. Burdin, N., L. Brossay, Y. Koezuka, S. T. Smiley, M. J. Grusby, M. Gui, M. Taniguchi, K. Hayakawa, and M. Kronenberg. 1998. Selective ability of mouse CD1 to present glycolipids: alpha-galactosylceramide specifically stimulates V alpha 14+ NK T lymphocytes. J. Immunol. 161:3271-3281.
34. Moodycliffe, A. M., D. Nghiem, G. Clydesdale, and S. E. Ullrich. 2000. Immune suppression and skin cancer development: regulation by NKT cells. Nat. Immunol. 1:521-525.
35. Crowe, N. Y., J. M. Coquet, S. P. Berzins, K. Kyparissoudis, R. Keating, D. G. Pellicci, Y. Hayakawa, D. I. Godfrey, and M. J. Smyth. 2005. Differential antitumor immunity mediated by NKT cell subsets in vivo. J. Exp. Med. 202:1279-1288.
36. 2, IL-4, and IL-10 is responsible for UV-induced systemic immune suppression. J. Immunol. 160:3783-3789.
37. el-Ghorr, A. A., and M. Norval. 1997. The role of interleukin-4 in ultraviolet B light-induced immunosuppression. Immunology 92:26-32.
38. Cruz, P. D., Jr., R. E. Tigelaar, and P. R. Bergstresser. 1990. Langerhans cells that migrate to skin after intravenous infusion regulate the induction of contact hypersensitivity. J. Immunol. 144:2486-2492.
39. Dai, R., and J. W. Streilein. 1995. Sensitizing capacity of Langerhans' cells obtained from ultraviolet-B-exposed murine skin. Immunology 86:661-667.
40. Wang, L., S. C. Jameson, and K. A. Hogquist. 2009. Epidermal Langerhans cells are not required for UV-induced immunosuppression. J. Immunol. 183:5548-5553.
41. Schwarz, A., M. Noordegraaf, A. Maeda, K. Torii, B. E. Clausen, and T. Schwarz. 2010. Langerhans cells are required for UVR-induced immunosuppression. J. Invest. Dermatol. 130:1419-1427.
42. Fisher, M. S., and M. L. Kripke. 1982. Suppressor T lymphocytes control the development of primary skin cancers in ultraviolet-irradiated mice. Science 216:1133-1134.
43. Schwarz, A., A. Maeda, M. K. Wild, K. Kernebeck, N. Gross, Y. Aragane, S. Beissert, D. Vestweber, and T. Schwarz. 2004. Ultraviolet radiation-induced regulatory T cells not only inhibit the induction but can suppress the effector phase of contact hypersensitivity. J. Immunol. 172:1036-1043.
44. Loser, K., A. Mehling, S. Loeser, J. Apelt, A. Kuhn, S. Grabbe, T. Schwarz, J. M. Penninger, and S. Beissert. 2006. Epidermal RANKL controls regulatory T-cell numbers via activation of dendritic cells. Nat. Med. 12:1372-1379.
45. Mendiratta, S. K., W. D. Martin, S. Hong, A. Boesteanu, S. Joyce, and L. Van Kaer. 1997. CD1d1 mutant mice are deficient in natural T cells that promptly produce IL-4. Immunity 6:469-477.
46. Takagi, Y., H. Nakagawa, T. Yaginuma, Y. Takema, and G. Imokawa. 2005. An accumulation of glucosylceramide in the stratum corneum due to attenuated activity of beta-glucocerebrosidase is associated with the early phase of UVB-induced alteration in cutaneous barrier function. Arch. Dermatol. Res. 297:18-25.
47. Ghoreschi, K., P. Thomas, S. Breit, M. Dugas, R. Mailhammer, W. van Eden, R. van der Zee, T. Biedermann, J. Prinz, M. Mack, et al. 2003. Interleukin-4 therapy of psoriasis induces Th2 responses and improves human autoimmune disease. Nat. Med. 9:40-46.
48. Ullrich, S. E. 2005. Mechanisms underlying UV-induced immune suppression. Mutat. Res. 571:185-205.
49. Faveeuw, C., V. Angeli, J. Fontaine, C. Maliszewski, A. Capron, L. Van Kaer, M. Moser, M. Capron, and F. Trottein. 2002. Antigen presentation by CD1d contributes to the amplification of Th2 responses to Schistosoma mansoni glycoconjugates in mice. J. Immunol. 169:906-912.
50. Mallevaey, T., J. P. Zanetta, C. Faveeuw, J. Fontaine, E. Maes, F. Platt, M. Capron, M. L. de-Moraes, and F. Trottein. 2006. Activation of invariant NKT cells by the helminth parasite schistosoma mansoni. J. Immunol. 176:2476-2485.